+1 - Roche
+1 - Roche
+1 - Roche
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Roaccutane<br />
Declining within expectations<br />
400<br />
300<br />
200<br />
100<br />
0<br />
CHF m<br />
sales<br />
Q1 '99 Q1 '00 Q1 '01 Q1 '02 Q1 '03<br />
global (<strong>Roche</strong> & Chugai)<br />
-34 % 1<br />
1 local growth<br />
• US<br />
r<br />
– now two generics approved, one on<br />
the market in Q1 '03<br />
– general decline of the respective<br />
market segment by approx. -25 % in<br />
scripts vs. Q1 '02; in line with<br />
previous years<br />
• Pregnancy Prevention Program<br />
– in the EU recognized as a valuable<br />
safety initiative<br />
– CPMP harmonization requested and<br />
ongoing<br />
48
Change language